Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy

• Antonij Slavcev,
• Caner Süsal,
• Ilias Doxiadis

Affiliations

Antonij Slavcev

Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czechia

Caner Süsal

Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey

Ilias Doxiadis

Institute for Transfusion Medicine, University Hospital, Leipzig, Germany